Apr 222014
- Author: Jonathan Faiz
- Published: 22 April 2014
- Copyright: Wiley-VCH Verlag GmbH & Co. KGaA
- Source / Publisher: Angewandte Chemie International Edition
- Associated Societies: Gesellschaft Deutscher Chemiker (GDCh), Germany
- read at
The pharmaceutical industry is facing economic and strategic pressures to remain productive and profitable, and those involved in basic research in academia are encountering difficulties as funding is shifting toward more applied areas. Thus, the field of drug design and development can benefit from academic−industrial partnerships. In his Editorial, K. C. Nicolaou, Rice University, Houston, TX, USA, discusses the challenges and opportunities for such collaborations.
Sorry, the comment form is closed at this time.